News

Torrent Pharma acquires four brands from Dr Reddy’s laboratories

The four brands are Styptovit-E, Finast, Finast-T and Dynapress

Ahmedabad-based Torrent Pharmaceuticals has entered into an agreement with Dr Reddy’s Laboratories to acquire four of its brands Styptovit-E, Finast, Finast-T and Dynapress.

Styptovit-E, a gynaecology product with estimated market size of ~Rs 500 crores (AIOCD data set), will further strengthen Torrent’s presence in the therapy. The acquisition of Styptovit-E, Finast, Finast-T, and Dynapress, which are used in the treatment of Benign Prostatic Hyperplasia (BPH), will aid in Torrent’s presence in the urology therapy.

As per the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India. The complete integration and transition of the brands are
expected to be completed by June 2022.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close